E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.62 -$0.015-0.92% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 44.34% 49.17% -136.50% 54.51% -976.81%
Total Depreciation and Amortization -38.93% -17.35% -1.25% -1.83% 0.93%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -97.55% -53.15% 853.64% -92.28% 184.31%
Change in Net Operating Assets -574.80% 124.79% 2.51% -154.46% 185.80%
Cash from Operations -6.35% 17.80% 9.86% -25.35% 32.39%
Capital Expenditure -- -- -- 100.00% -352.50%
Sale of Property, Plant, and Equipment 11,180.00% -- -- -100.00% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -26.33% 25.36% -33.08% 39.41% -43.81%
Cash from Investing -24.95% 25.38% -33.08% 39.88% -43.96%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -100.00% -- -100.00% 922.22% -96.37%
Repurchase of Common Stock -- -- -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -100.00% -- -100.00% 922.22% 28.57%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -153.94% 208.21% -272.94% 770.31% -106.68%